Pharmacokinetics and safety of viramidine, a prodrug of ribavirin, in healthy volunteers.
D000284:Administration, Oral; D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics / Q000652:urine; D019540:Area Under Curve; D002214:Capsules; D002851:Chromatography, High Pressure Liquid; D004041:Dietary Fats; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D018565:Food-Drug Interactions; D006207:Half-Life; D006801:Humans; D008297:Male; D013058:Mass Spectrometry; D008875:Middle Aged; D011355:Prodrugs / Q000009:adverse effects / Q000493:pharmacokinetics*; D012254:Ribavirin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine; D013997:Time Factors
D000998:Antiviral Agents; D002214:Capsules; D004041:Dietary Fats; D011355:Prodrugs; D012254:Ribavirin; C026956:taribavirin